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Edited by Maurice MontalAbstract Lymphocyte signaling and activation leads to the in-
ﬂux of extracellular Ca2+ via the activation of Ca2+ release acti-
vated Ca2+ (CRAC) channels in the plasma membrane.
Activation of CRAC channels occurs following emptying of the
endoplasmic reticulum intracellular Ca2+ stores. One model to
explain the coupling of store-emptying to CRAC activation is
the secretion-like conformational coupling model. This model
proposes that store depletion increases junctions between the
endoplasmic reticulum and the plasma membrane in a manner
that could be regulated by the cortical actin cytoskeleton. Here,
we show that stabilization or depolymerization of the actin cyto-
skeleton failed to aﬀect CRAC activation. We therefore con-
clude that rearrangement of the actin cytoskeleton is
dispensable for store-operated Ca2+ entry in T-cells.
 2007 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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Ca2+ is one of the most fundamental signaling messengers in
all eukaryotic cells. Cytosolic Ca2+ signals are the key to the
regulation of a wide variety of physiological events, such as
gene transcription, protein folding, apoptosis and exocytosis.
Following stimulation of lymphocytes or other non-excitable
cells, bi-phasic increases in the intracellular Ca2+ concentration
([Ca2+]i) are observed [1–3]. The ﬁrst phase involves activation
of phospholipase C by either trimeric G proteins or tyrosine ki-
nase coupled receptors [4]. The active enzyme hydrolyzes phos-
phatidylinositol bisphosphate, thus generating the second
messenger inositol-1,4,5-trisphosphate (IP3), which binds to
IP3 receptor molecules within the endoplasmic reticulum
(ER) membrane, thereby triggering Ca2+ release from ER
Ca2+ stores [2]. In a second phase, store-emptying triggers a
sustained inﬂux of extracellular calcium via the plasma mem-
brane, a process termed store-operated calcium entry (SOC)
or capacitive calcium entry [5–7]. Diﬀerent models exists as
to explain how the emptying of ER stores results in the activa-
tion of Ca2+ inﬂux via the plasma membrane. A ﬁrst model
postulates a mobile messenger that links store content to plas-
ma membrane channel activation. Such a messenger could be a*Corresponding author. Fax: +41 61 267 21 48.
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released upon ER store depletion, or is generated de novo
within the cytosol and/or ER/plasma membrane [8–13]. A sec-
ond model is based on transport of vesicles to the plasma
membrane inserting Ca2+ channels into the plasma membrane
via fusion following store-emptying [14]. Third, the secretion-
like coupling model postulates migration of the endoplasmic
reticulum to the plasma membrane in order to locally activate
CRAC channels [15,16]. Coupling of store depletion to the
activation of CRAC channels is believed to occur via the stro-
mal interaction molecules (STIM) 1 and 2 by relocalizing with-
in the endoplasmic reticulum to preformed endoplasmic
reticulum–plasma membrane contact sites. [17–21].
The secretion-like coupling model is based on results ob-
tained using a variety of F-actin-modulating drugs that suggest
the involvement of the cortical actin cytoskeleton in the inter-
action of ER stores with plasma membrane channels following
depletion. For example, studies in a variety of cell types such
as smooth muscle cells, platelets, endothelial cells, glioma cells,
and pancreatic acinar cells suggest a role for actin in the cou-
pling of store depletion to the activation of store-operated cal-
cium entry (SOC) [15,22–24]. Induced polymerization of the
cortical actin cytoskeleton by a variety of drugs resulted in
the ablation of store-operated calcium entry, suggesting that
actin polymerization acts as a physical barrier in preventing
the translocation of the endoplasmic reticulum to the plasma
membrane [25]. However, in RBL cells, stabilization or disas-
sembly of the actin cytoskeleton fails to aﬀect Ca2+ inﬂux via
store-operated CRAC channels [26], suggesting that the contri-
bution of the cortical actin cytoskeleton may be cell type
dependent. These divergent ﬁndings could indicate that cou-
pling to CRAC channels is aﬀected diﬀerently by the activity
of actin-modulating drugs in diﬀerent cell types. Alternatively,
in some cell types, store-operated calcium entry may predom-
inantly occur through other classes of calcium channels.
A role for the actin cytoskeleton in T-cells has not been de-
scribed. In this work, we have analyzed the involvement of the
actin cytoskeleton in CRAC activation in Jurkat T-cells, and
found that modulation of the actin cytoskeleton by either sta-
bilizing or disassembling actin has no signiﬁcant eﬀect on the
activation or function of CRAC channels.2. Materials and methods
2.1. Cells and reagents
Human Jurkat T-cells were grown in medium consisting of RPMI
1640 (Gibco) supplemented with 2 mM L-glutamine (Gibco), 10%ation of European Biochemical Societies.
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were obtained from Calbiochem, Thapsigargin, Latrunculin B and
Cytochalasin D were from Sigma.
2.2. Analysis of F-actin and G-actin
The relative proportions of G-actin and F-actin in Jurkat T-cells
were analyzed by sedimentation of ﬁlamentous actin followed by the
quantitative determination of F- and G-actin by SDS–PAGE [27]. In
brief, cells were left untreated or treated with Jasplakinolide (1 lM),
Latrunculin B (4 lM) or Cytochalasin D (10 lM) for 30 min at room
temperature followed by lysis (also at RT) in 200 ll F-actin stabiliza-
tion buﬀer for 10 min (50 mM PIPES), pH 6.9, 50 mM NaCl, 5 mM
MgCl2, 5 mM EGTA, 5% glycerol, 0.1% Triton X-100, 0.1% NP-40,
0.1% Tween 20, 0.1% betamercaptoethanol, 1 mM ATP, protease
(complete EDTA free cocktail, Roche) and phosphatase inhibitor
(HALT phosphatase cocktail, Pierce). Cell lysis was followed by try-
pan blue exclusion microscopy. Cell lysates were sedimented at
150000 · g for 60 min at 37 C. The pellets were resuspended in
200 ll ice cold distilled water containing Cytochalasin D (10 lM)
and incubated at 4 C for 60 min to depolymerize the F-actin. The
resuspended pellet was gently mixed every 15 min. Ten microliters of
supernatant (G-actin) and pellet (F-actin) fractions were subjected to
analysis by immunoblotting following SDS–PAGE. Actin was detected
using anti-actin antibody (MAB 1501, Chemicon (1:1000)).
2.3. Immunoﬂuorescence microscopy
Cells were adhered on poly-L-lysine treated 10 well Teﬂon-coated
glass slides (Polysciences) for 15 min and left either untreated or trea-
ted with Jasplakinolide (1 lM), Latrunculin B (4 lM) or Cytochalasin
D (10 lM) for 30 min at room temperature. After ﬁxation (20 min, 4%
paraformaldehyde in PBS, 37 C) and permeabilization in 0.2% sapo-
nin/3% BSA in PBS, cells were stained overnight with phalloidin-
AlexaFluor568 (Molecular Probes) in 0.2% saponin/3% BSA/PBS at
4 C. Overnight labeling was necessary to allow phalloidin-Alexa-
Fluor568 to compete with and displace Jasplakinolide, since Jasplaki-
nolide binds to the same site as phalloidin [28].
2.4. Flow cytometric measurements of intracellular Ca2+
Jurkat T-cells were washed with medium, RPMI 1640 (Gibco)/10%
heat inactivated FBS (Gibco)/2 mM L-glutamine (Gibco-BRL) and
loaded with 2.0 lg/ml of Indo1 (Molecular Probes) for 45 min at
37 C in the dark. After loading, cells were washed two times in med-
ium and left either untreated or were incubated with Jasplakinolide
(1 lM), Latrunculin B (4 lM) or Cytochalasin D (10 lM) for 20 min
at RT. Cell were washed twice with Ca2+ free Ringer solution in the
presence of the drugs (total of 10 min) and taken up in Ca2+ free Ring-
er solution containing 1 mM EGTA (1 ml) and the indicated drugs.
After acquiring a baseline for 30 s cells were triggered with 1 lM of
Thapsigargin to induce ER Ca2+ store release. After a total time of
8 min 500 ll of cell suspension was transferred to a new tube withFig. 1. Eﬀect of actin-modulating drugs on the F-actin cytoskeleton. Jurkat
Latrunculin B (Lat B, 4 lM; B), Cytochalasin D (Cyt D, 10 lM; C) or Jasp
with phalloidin-Alexa Fluor 568. Bar: 10 lM.500 lL 2 mM calcium containing Ringer. 2-APB, either 3 lM to en-
hance Ca2+ inﬂux or 100 lM to inhibit calcium inﬂux were added as
indicated in Fig. 3. Ca2+ measurements were all done on a LSR II (Bec-
ton Dickinson). Data were analyzed using FlowJo software.
2.5. Electrophysiology
Patch-clamp experiments were performed at 22–23 C in the tight-
seal whole-cell conﬁguration using ﬁre-polished patch pipettes (2–
5 MX uncompensated series resistance). Pipette and cell capacitance
were electronically cancelled before each voltage ramp with an EPC-
9 patch-clamp ampliﬁer controlled by Pulse 8.4 software (Heka elek-
tronik). Membrane currents were ﬁltered at 1.5–2.3 kHz and digitized
at a sampling rate of 5–10 kHz. Whole-cell currents were elicited by
200 ms voltage-clamp ramps from 100 mV to +100 mV from a hold-
ing potential of 0 mV. To measure leak currents before activation of
store-operated currents, 20 voltage ramps were applied within the ﬁrst
5 s after establishment of the whole-cell conﬁguration, followed by
voltage ramps applied every second. All voltages were corrected for
a liquid junction potential of 12 mV between internal solutions and
the bath solution. The standard pipette solution for whole-cell patch-
clamp recordings contained (in mM): 0.05 InsP3, 0.00005 TG, 10
EGTA, 140 Cs-aspartate, 2 MgCl2, 5 Mg-ATP, 0.5 Tris-GTP, 2.5
malic acid, 2.5 Na-pyruvat, 1 NaH2PO4 and 10 Hepes (pH 7.2 with
CsOH). The extracellular solution contained (in mM): 101.66 NaCl,
3 KCl, 20.66 CaCl2, 1.22 MgCl2, 6.66 D-glucose, and 3.33 Hepes
(pH 7.4 with NaOH).3. Results
3.1. Modulation of the T-cell cytoskeleton by actin interfering
drugs
To analyze whether in T-cells the cortical actin cytoskeleton
can be disassembled by actin-interfering drugs, Jurkat T-cells
were left untreated or incubated with Latrunculin B or Cyto-
chalasin D. Whereas both Latrunculin B and Cytochalasin D
disrupt F-actin ﬁlaments, they do so by diﬀerent mechanisms.
Latrunculin B is a marine toxin isolated from the Red Sea
sponge Latrunculia magniﬁca, and inhibits actin polymeriza-
tion by binding to G-actin [29,30]. Cytochalasin D disrupt
the F-actin cytoskeleton by binding to the barbed, fast growing
end of actin ﬁlaments inhibiting their elongation thereby pre-
venting polymerization [31,32]. Following treatment, cells were
ﬁxed and stained for F-actin using phalloidin coupled to
Alexa-568 to visualize F-actin and processed for immunoﬂuo-
rescence microscopy. As shown in Fig. 1A–C, while the F-actinT-cells were left untreated (A) or were treated for 30 min at RT with
lakinolide (Jasp, 1 lM; D). Cells were ﬁxed and F-actin was visualized
Fig. 2. Biochemical analysis of F/G-actin from T-cells treated with actin-modulating drugs. Jurkat T-cells were left untreated or treated with either
Jasplakinolide (1 lM), Latrunculin B (4 lM) or Cytochalasin D (10 lM) for 30 min at RT followed by cell lysis. Proteins present in supernatant (S)
and pellet (P) were prepared as described in methods, separated by SDS–PAGE and immunoblotted using anti-actin antibodies. The supernatant
resembles the soluble or G-actin whereas the pellet corresponds to the F-actin.
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indicated by the phalloidin staining, following incubation
with Latrunculin B and Cytochalasin D, F-actin was barely
detectible. In contrast to the action of Latrunculin B and Cyto-
chalasin D, the fungal peptide Jasplakinolide induces polymer-
ization of F-actin by enhancing the rate of actin ﬁlament
nucleation [28]. When T-cells were treated for 30 min with
Jasplakinolide, followed by ﬁxation and visualization of F-ac-
tin by phalloidin, the cortical actin was drastically enhanced
compared to non-treated cells (Fig. 1A,D).Fig. 3. Calcium Fluorimetry in the presence and absence of actin-modulating
and calcium inﬂux was analyzed in cells treated for 30 min with the indicated
used at 1 lM, Latrunculin B at 4 lM and Cytochalasin D at 10 lM. After 8 m
enhance calcium inﬂux and at 14 min 100 lM 2-APB was added to block calc
A–C (Control) or without 2-APB treatment (no 2-APB) or the solvent DM
treatment (DMSO).Induction of F-actin polymerization or depolymerization by
these actin-modulating drugs was mirrored using a biochemi-
cal assay to separate ﬁlamentous actin from G-actin [27,33].
Cells were left untreated or treated with the drugs indicated
in Fig. 2 for 30 min, followed by cell lysis and sedimentation
of F-actin. Quantitative recovery of F-actin was achieved by
depolymerization using Cytochalasin D followed by SDS–
PAGE analysis and immunoblotting. As shown in Fig. 2, while
in control cells similar amounts of G-versus F-actin were
recovered, following Jasplakinolide treatment of the cells vir-drugs. (A–C) Jurkat T-cells were processed as described under methods
actin-modulating drugs or left untreated as control. Jasplakinolide was
in calcium was added to the cells, at 12 min 3 lM 2-APB was added to
ium inﬂux. (D) Additional control samples of untreated cells, as under
SO used instead of Thapsigargin dissolved in DMSO without 2-APB
Fig. 4. Eﬀect of actin-modulating drugs on CRAC current. (A) CRAC
current recordings at 80 mV in the presence or absence of Jasplak-
inolide (1 lM) or Latrunculin B (10 lg/ml) following a 20–30 minutes
pre-incubation with the drugs. (B) Average of maximal CRAC
currents in control cells (n = 13), in latrunculin-treated cells (n = 8)
or in Jasplakinolide-treated cells (n = 4).
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indicating massive polymerization of actin upon Jasplakinolide
treatment (Fig. 2, Jasp). Conversably, when cells were treated
with either Latrunculin B or Cytochalasin D, almost all cellu-
lar actin was recovered in the soluble fraction, indicating com-
plete depolymerization. Together the morphological and
biochemical results suggest that the polymerization and depo-
lymerization of the actin cytoskeleton can be achieved eﬃ-
ciently in human T-cells using these F-actin-modulating drugs.
3.2. Store-operated calcium mobilization following disruption of
the actin cytoskeleton
The actin cytoskeleton has been proposed to play an impor-
tant role in the coupling of the endoplasmic reticulum stores to
store-operated Ca2+ channels at the plasma membrane. In a
variety of cell type, both depolymerization as well as polymer-
ization of F-actin results in the inhibition of store-operated
Ca2+ inﬂux [15,24,25,34–37]. To analyze whether store-oper-
ated Ca2+ inﬂux in T-cells is dependent on the actin cytoskel-
eton, cells were incubated for 30 min. with Jasplakinolide to
induce complete F-actin polymerization. Store depletion was
initiated by Thapsigargin which induces store depletion by
blocking the Ca2+ SERCA pumps in the endoplasmic reticu-
lum thereby preventing Ca2+ uptake within the ER stores
[38]. As shown in Fig. 3A, Jasplakinolide incubation did nei-
ther alter release of Ca2+ from stores by Thapsigargin nor
Ca2+ inﬂux through CRAC channels as measured by Ca2+
re-addition (Fig. 3A). The pharmacological modulation of
CRAC channels by 2-APB is considered a hallmark of store-
operated Ca2+ inﬂux through CRAC channels. Whereas
2APB increases CRAC activity at a concentration below
10 lM, it inhibits CRAC activity at higher concentrations
[39,40]. As a control for CRAC channel activity, cells were
treated with 3 lM 2-APB after re-addition of Ca2+ to elevate
Ca2+ inﬂux and sequentially with 100 lM 2-APB to completely
block Ca2+ inﬂux, resulting in the typical bi-phasic behavior of
CRAC channel mediated Ca2+ entry (Fig. 3A).
Similar to the eﬀect of Jasplakinolide, incubation of T-cells
with the F-actin depolymerizing drugs Cytochalasin D or
Latrunculin B did not signiﬁcantly modulate Ca2+ entry fol-
lowing store depletion (Fig. 3B and C). Together these results
suggest that polymerization or depolymerization of the actin
cytoskeleton do not aﬀect cytosolic Ca2+ inﬂux in T-cells.
3.3. Patch-clamp analysis in the presence and absence of actin-
modulating drugs
To directly analyze the inﬂuence of disturbance of the actin
cytoskeleton on CRAC channel activity, patch-clamp experi-
ments were performed. As shown in Fig. 4, the presence of nei-
ther Latrunculin B nor Jasplakinolide signiﬁcantly inﬂuenced
the amplitude of CRAC currents in T-cells. We conclude that
neither polymerization nor depolymerization of the actin cyto-
skeleton alter Ca2+ inﬂux through CRAC channels in T-cells.4. Discussion
The processes that regulate the inﬂux of Ca2+ following T-
cell activation are not fully understood. After T-cell activation,
the endoplasmic reticulum Ca2+ stores are depleted, which re-
sults in the activation of store-operated CRAC/ORAI1 chan-
nels at the plasma membrane in a STIM1 dependent manner[7,18,20,40–42]. While in a variety of cell types, the activation
of store-operated Ca2+ channels has been suggested to be reg-
ulated by the F-actin cytoskeleton, we here describe that in T-
cells, as is the case for RBL cells [26], CRAC activation was
fully independent of rearrangement of the F-actin cytoskele-
ton, as analyzed by Ca2+ imaging and patch-clamp analysis
of cells whose F-actin cytoskeleton was drastically disturbed
by actin poisoning reagents.
Evidence for a role of the cortical actin cytoskeleton is sup-
ported by experiments in which drugs similar to the ones used
here showed a decrease of SOC dependent Ca2+ signals in
smooth muscle cells, platelets, endothelial cells, glioma cells,
and pancreatic acinar cells [25]. How can one reconcile these
apparent diﬀerences concerning the inﬂuence of actin polymer-
ization or depolymerization on SOC channel activity observed
between diﬀerent cells types?
First, it is possible that Ca2+ entry channels in the cell types
mentioned above are regulated by the actin cytoskeleton; for
example, upon growth factor stimulation, members of the
transient receptor potential (TRP) calcium inﬂux channels un-
dergo regulated exocytosis to be inserted at the plasma mem-
brane, a step that could well involve the actin cytoskeleton
[43,44]. Also, in platelets and smooth muscle cells, the cortical
actin cytoskeleton is tightly linked to the plasma membrane via
proteins such as ﬁlamin and dystrophin, and polymerization of
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ER with plasma membrane Ca2+ channels [45,46]. The precise
mode of coupling emptied ER stores to plasma membrane
Ca2+ channels may thus be distinct in diﬀerent cell types.
For example, it is possible that the subcellular organization
of the endoplasmic reticulum in smooth muscle cells and plate-
lets is diﬀerent from that of RBL and T-cells.
Recent work in T-cells revealed that the majority of contact
sites between the ER and the plasma membrane are already
preformed in resting cells [19]. Upon Ca2+ release, the number
of STIM1 junctional contact sites increase signiﬁcantly, prob-
ably since STIM1 proteins within the ER membrane move to
those preformed membrane junctions in order to form the
puncta that mediate the activation of CRAC channels. Since
formation of STIM puncta beneath plasma membrane mainly
depends on STIM recruitment rather than migration of ER
membranes towards the plasma membrane, it is plausible that
neither depolymerization nor polymerization of cortical actin
aﬀects CRAC activity in T-cells, as reported here [42].
An alternative explanation for the observed discrepancies
are the methodologies used to analyze Ca2+ signaling. While
in the study presented here, patch-clamp measurements of
CRAC and Ca2+ imaging by ﬂow cytometry was used to ana-
lyze a potential inﬂuence of the actin cytoskeleton on CRAC
activity, most of the other studies rely solely on Ca2+ imaging.
While both techniques have their advantages and disadvan-
tages [47], Ca2+ imaging alone does not allow to distinguish ef-
fects of the actin cytoskeleton on Ca2+ inﬂux channels,
membrane potential, Ca2+ buﬀering or Ca2+ export mecha-
nisms such as Ca2+ ATPases or mitochondrial Ca2+ uptake,
all of which contribute to Ca2+ signals [48]. Interestingly, the
conclusion that modulation of the actin cytoskeleton aﬀects
store-operated Ca2+ entry was solely based on experiments
involving Ca2+ imaging [15,22–25,37]. It therefore can not be
exclude that the target of the actin cytoskeleton was not the
SOC channel itself but rather for example a K+ channel, since
inhibition of a K+ channel would depolarize the membrane po-
tential thereby resulting in a reduced Ca2+ entry through SOC
channels. Harper and Sage have in fact recently shown that in
platelets, which have been used as a prominent model system
to analyze the inﬂuence of the actin cytoskeleton on store-
operated Ca2+ entry, the Na+–Ca2+ exchanger but not SOC
was modulated by the actin cytoskeleton. In T-cells, Na+–
Ca2+ exchange appears not to be of functional importance
[49,50], and therefore our conclusion that the cortical actin
cytoskeleton does not aﬀect store-operated Ca2+ channels in
T-cells is consistent with these data.
While our results exclude a role for the F-actin cytoskeleton
in CRAC activation in T-cells, the actin cytoskeleton does play
a role at other levels of the signaling cascade leading to T-cell
activation. In T-cells deﬁcient for the Wiskott–Aldrich syn-
drome protein (WASp) or the WASP interacting protein
WIP, both of which are involved in the regulation of the actin
cytoskeleton, T-cell activation is deﬁcient but at a step that lies
upstream of store depletion [51–53]. Similarly, T-cells deﬁcient
in Vav, a guanine–nucleotide exchange factor for the GTPase
Rac which modulates the actin cytoskeleton, cannot properly
be activated because of pleiotropic defects related to T-cell
receptor clustering [54]. Interestingly, in cells in which expres-
sion of the WASP-family verprolin (WAVE)-homologous pro-
tein is knocked down, signaling events immediately
downstream of the T-cell receptor are defective [55,56]; in addi-tion, the absence of WAVE inhibits store-operated Ca2+ entry
[56]. It should be noted, however, that in natural killer cells the
WASp protein regulates the nuclear translocation of transcrip-
tion factors, which occurs downstream of store-operated Ca2+
inﬂux, independently of its eﬀect on the actin cytoskeleton [57].
The process that couples depletion of intracellular stores to
plasma membrane Ca2+ channels is crucial for the proper func-
tioning of T-cells since a defect in this pathway would render
T-cells unresponsive towards immunological stimuli. However,
the precise pathways leading to activation of plasma mem-
brane Ca2+ channels are far from being deﬁned. Whereas in
certain cell types, the cortical actin cytoskeleton may play a
role in this activation pathway, our work reported here shows
that in T-cells actin rearrangement is dispensable for coupling
the intracellular store release to plasma membrane CRAC
channels.
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